In brain tumors, lacking VRK1, this compensatory mechanism is impaired by silencing the VRK2 gene, and thus no VRK2 isoform can partially replace VRK1 [167], and cells become more sensitive to DNA damage [166]. This evidence concerns the gene VRK1 and brain neoplasm.